Clinical trial
Harvesting Cells for Experimental Cancer Treatments
NCT00068003 · National Cancer Institute (NCI), NIH · Enrolling by invitation
Key facts
| NCT number | NCT00068003 |
|---|---|
| Title | Harvesting Cells for Experimental Cancer Treatments |
| Official title | Cell Harvest and Preparation for Surgery Branch Treatment Protocols |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Enrolling by invitation |
| Study type | Observational |
| Conditions | Melanoma, Gastrointestinal Cancer, Metastatic Cancer, Breast Cancer, Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Anti-CD19 CAR PBL |
| Enrollment | 7,000 |
| Start date | Sep 8, 2003 |
| First posted | Sep 4, 2003 |
| Last update posted | Dec 31, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: